Cerus Corp.

NASDAQ:CERS 4:00:00 PM EDT

1.68

-0.05 (-2.89%)

4:29:13 PM EDT: $1.66 -0.02 (-1.19%)

Market Cap (Intraday)	304.56M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$43.29 Million
Adjusted EPS	-$0.05

See more estimates

10-Day MA	$1.77
50-Day MA	$2.05
200-Day MA	$1.92

See more pivots

Cerus Corp. Stock, NASDAQ:CERS

1220 Concord Avenue, Suite 600, Concord, California 94520

United States of America

Phone: +1.925.288.6000

Number of Employees: 288

http://www.cerus.com

Description

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.